IN8BIO REPORTS UPDATED GLIOBLASTOMA DATA AT SNO 2026 DEMONSTRATING MEDIAN OVERALL SURVIVAL OF 20.9 MONTHS AND 50% TWO-YEAR SURVIVAL WITH GAMMA-DELTA T CELL THERAPY

Reuters · 3d ago

Please log in to view news